Lesigercept

N/A

Report date: 2026/04/14 20:00:15

Base Information

Drug NameLesigercept
Drug Alias NameIgE TrapFc protein (Yuhan)YH-35324GI-301
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionIgE Fc receptor, alpha-subunit antagonists
TargetsIgE Fc receptor, alpha-subunit
Therapy Area/IndicationsHypersensitivityImmune System DiseasesChronic Urticaria +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaPolandSouth Korea +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesYuhan Corp
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Kendlewits Medical Consulting Co LtdMaruho Co LtdYuhan Corp
Inactive CompaniesN/A
Active IndicationsHypersensitivityChronic UrticariaUrticaria +[4] 
Inactive IndicationsImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A